 |
|||||
|
|
| Fwek Directory // Business // Biotechnology and Pharmaceuticals |  |
|
|
Mon, 21 May 2012 03:30:00 -0700
Pacira Pharmaceuticals, Inc. today announced that it has been selected for inclusion in the NASDAQ Biotechnology Index® effective today. The National B
Read More...
Wed, 23 May 2012 05:02:51 -0700
CAMBRIDGE, Mass. & NORWICH, United Kingdom--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Plant Bioscience Limited (PBL), a technology development and intellectual property (IP) management company, announced today that they have entered into a licensing agreement. PBL has granted Alnylam a world-wide, non-exclusive license to the ...
Read More...
Wed, 23 May 2012 05:00:00 -0700
Tonix Pharmaceuticals Holding Corp. , a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system , including fibromyalgia syndrome and post-traumatic stress disorder , today announced that Chief Executive Officer Seth Lederman, MD, was interviewed by CEOLive.TV.
Read More...
Fri, 18 May 2012 05:45:00 -0700
New York Biotechnology Association , the voice of New York State’s bioscience industry, today announced that the 2012 honorees of the Association’s annual leadership awards will be the leaders of Regeneron Pharmaceuticals, New York’s largest biotechnology company: Dr.
Read More...
Tue, 08 May 2012 04:00:00 -0700
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the Bank of America Merrill Lynch 2012 Health Care Conference being held at Encore at the Wynn Hotel in Las Vegas, Nevada.
Read More...
Tue, 15 May 2012 05:00:00 -0700
Infinity Pharmaceuticals, Inc. today announced that the company will be added to the NASDAQ Biotechnology Index® . The semi-annual re-ranking of the index will
Read More...
Thu, 17 May 2012 04:00:00 -0700
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN® Injection for intravenous use + rituximab in combination with motexafin gadolinium in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin ...
Read More...
Tue, 01 May 2012 04:00:00 -0700
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the 37th Annual Deutsche Bank Health Care Conference being held at The InterContinental Boston in Boston, Massachusetts.
Read More...
Tue, 22 May 2012 04:30:00 -0700
BOSTON, May 22, 2012 /PRNewswire/-- Paratek Pharmaceuticals, Inc. today announced that Dennis Molnar, formerly Paratek's Vice President, Corporate Development, has been appointed President, Chief Executive ...
Read More...
Wed, 23 May 2012 13:15:00 -0700
Baxter International Inc. announced today that it will present at the Goldman Sachs 33rd Annual Global Healthcare Conference on Wednesday, June 6, 2012, at 2:00 p.m. PT
Read More...
Home | Submit Link | Latest Links | Top Hits Powered by: PHP Link Directory | Copyright 2008 , All rights reserved.